122 related articles for article (PubMed ID: 37883920)
1. Outcomes of the IMMray PanCan-d Test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned.
Katona BW; Worthington C; Clay D; Cincotta H; Ahmad NA; Ginsberg GG; Kochman ML; Brand RE
JCO Precis Oncol; 2023 Sep; 7():e2300445. PubMed ID: 37883920
[TBL] [Abstract][Full Text] [Related]
2. Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study.
Brand RE; Persson J; Bratlie SO; Chung DC; Katona BW; Carrato A; Castillo M; Earl J; Kokkola A; Lucas AL; Moser AJ; DeCicco C; Mellby LD; King TC
Clin Transl Gastroenterol; 2022 Feb; 13(3):e00468. PubMed ID: 35166713
[TBL] [Abstract][Full Text] [Related]
3. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
[TBL] [Abstract][Full Text] [Related]
4. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
Canto MI; Hruban RH; Fishman EK; Kamel IR; Schulick R; Zhang Z; Topazian M; Takahashi N; Fletcher J; Petersen G; Klein AP; Axilbund J; Griffin C; Syngal S; Saltzman JR; Mortele KJ; Lee J; Tamm E; Vikram R; Bhosale P; Margolis D; Farrell J; Goggins M;
Gastroenterology; 2012 Apr; 142(4):796-804; quiz e14-5. PubMed ID: 22245846
[TBL] [Abstract][Full Text] [Related]
5. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?
Wang Y; Cuggia A; Chen YI; Parent J; Stanek A; Denroche RE; Zhang A; Grant RC; Domecq C; Golesworthy B; Shwaartz C; Borgida A; Holter S; Wilson JM; Chong G; O'Kane GM; Knox JJ; Fischer SE; Gallinger S; Gao ZH; Foulkes WD; Waschke KA; Zogopoulos G
J Natl Compr Canc Netw; 2022 Jun; 20(6):663-673.e12. PubMed ID: 35714671
[TBL] [Abstract][Full Text] [Related]
6. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
[TBL] [Abstract][Full Text] [Related]
7. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in
Saldia A; Olson SH; Nunes P; Liang X; Samson ML; Salo-Mullen E; Marcell V; Stadler ZK; Allen PJ; Offit K; Kurtz RC
Cancer Prev Res (Phila); 2019 Sep; 12(9):599-608. PubMed ID: 31337648
[TBL] [Abstract][Full Text] [Related]
9. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
10. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
11. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
Zogopoulos G; Haimi I; Sanoba SA; Everett JN; Wang Y; Katona BW; Farrell JJ; Grossberg AJ; Paiella S; Klute KA; Bi Y; Wallace MB; Kwon RS; Stoffel EM; Wadlow RC; Sussman DA; Merchant NB; Permuth JB; Golan T; Raitses-Gurevich M; Lowy AM; Liau J; Jeter JM; Lindberg JM; Chung DC; Earl J; Brentnall TA; Schrader KA; Kaul V; Huang C; Chandarana H; Smerdon C; Graff JJ; Kastrinos F; Kupfer SS; Lucas AL; Sears RC; Brand RE; Parmigiani G; Simeone DM;
J Natl Compr Canc Netw; 2024 Apr; 22(3):158-166. PubMed ID: 38626807
[TBL] [Abstract][Full Text] [Related]
12. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
13. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
14. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
15. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.
Katona BW; Klute K; Brand RE; Everett JN; Farrell JJ; Hawthorne K; Kaul V; Kupfer SS; Paiella S; Simeone DM; Sussman DA; Zogopoulos G; Lucas AL; Kastrinos F;
Cancer Prev Res (Phila); 2023 Jun; 16(6):343-352. PubMed ID: 37259800
[TBL] [Abstract][Full Text] [Related]
16. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
Roch AM; Kim RC; Nguyen TK; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
J Surg Oncol; 2023 Aug; 128(2):289-294. PubMed ID: 37083062
[TBL] [Abstract][Full Text] [Related]
17. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
18. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
[TBL] [Abstract][Full Text] [Related]
19. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Psychosocial Impact of Pancreatic Cancer Surveillance in High-Risk Individuals.
Anez-Bruzual I; Coughlin S; Clay D; Heiman J; Dungan M; Weber M; Almario CV; Leung G; Ahmad NA; Ginsberg GG; Kochman ML; Valverde KD; Long JM; Katona BW
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]